Literature DB >> 27549227

Prevention and management of vision loss relating to facial filler injections.

Kwok Thye David Loh1, Jun Jin Chua2, Hung Ming Lee3, Joyce Teng-Ee Lim4, Gerard Chuah5, Benjamin Yim6, Boon Kwang Puah7.   

Abstract

INTRODUCTION: With the increased use of filler and fat injections for aesthetic purposes, there has been a corresponding increase in the incidence of complications. Vision loss as an uncommon but devastating vascular side effect of filler injections was the focus of this paper.
METHODS: A review committee, consisting of plastic surgeons, aesthetic medical practitioners, ophthalmologists and dermatologists from Singapore, was convened by the Society of Aesthetic Medicine (Singapore) to review and recommend methods for the prevention and management of vision loss secondary to filler injections.
RESULTS: The committee agreed that prevention through proper understanding of facial anatomy and good injection techniques was of foremost importance. The committee acknowledged that there is currently no standard management for these cases. Based on existing knowledge, injectors may follow a proposed course of action, which can be divided into immediate, definitive and supportive. The goals were to reduce intraocular pressure, dislodge the embolus to a more peripheral location, remove or reverse central ischaemia, preserve residual retinal function, and prevent the deterioration of vision. Dissolving a hyaluronic acid embolus remains a controversial option. It is proposed that injectors must be trained to recognise symptoms, institute immediate actions and refer patients without delay to dedicated specialists for definitive and supportive management.
CONCLUSIONS: Steps to prevent and manage vision loss based on current evidence and best clinical practices are outlined in this paper. Empirical referral to any emergency department or untrained doctors may lead to inordinate delays and poor outcomes for the affected eye. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  aesthetic medicine; blindness; facial fillers; filler injection; hyaluronic acid

Mesh:

Substances:

Year:  2016        PMID: 27549227      PMCID: PMC4993968          DOI: 10.11622/smedj.2016134

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  13 in total

1.  Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers.

Authors:  Keita Inoue; Katsujiro Sato; Daisuke Matsumoto; Koichi Gonda; Kotaro Yoshimura
Journal:  Plast Reconstr Surg       Date:  2008-03       Impact factor: 4.730

2.  Fundus artery occlusion caused by cosmetic facial injections.

Authors:  Yanyun Chen; Wenying Wang; Jipeng Li; Yajie Yu; Lin Li; Ning Lu
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

3.  A cadaveric feasibility study of the intraorbital cannula injections of hyaluronidase for initial salvation of the ophthalmic artery occlusion.

Authors:  Tanvaa Tansatit; Prawit Apinuntrum; Thavorn Phetudom
Journal:  Aesthetic Plast Surg       Date:  2015-02-18       Impact factor: 2.326

4.  Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections: a national survey by the Korean Retina Society.

Authors:  Kyu Hyung Park; Yong-Kyu Kim; Se Joon Woo; Se Woong Kang; Won Ki Lee; Kyung Seek Choi; Hyung Woo Kwak; Ill Han Yoon; Kuhl Huh; Jong Woo Kim
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

5.  Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.

Authors:  Deok-Woo Kim; Eul-Sik Yoon; Yi-Hwa Ji; Seung-Ha Park; Byung-Il Lee; Eun-Sang Dhong
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-07-31       Impact factor: 2.740

6.  Verification of Embolic Channel Causing Blindness Following Filler Injection.

Authors:  Tanvaa Tansatit; Hyoung Jin Moon; Prawit Apinuntrum; Thavorn Phetudom
Journal:  Aesthetic Plast Surg       Date:  2014-12-06       Impact factor: 2.326

7.  Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections.

Authors:  Sung Wook Park; Se Joon Woo; Kyu Hyung Park; Jang Won Huh; Cheolkyu Jung; O-Ki Kwon
Journal:  Am J Ophthalmol       Date:  2012-07-25       Impact factor: 5.258

Review 8.  Patient factors influencing dermal filler complications: prevention, assessment, and treatment.

Authors:  Koenraad De Boulle; Izolda Heydenrych
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-15

9.  Partial vision recovery after iatrogenic retinal artery occlusion.

Authors:  Shu-Fang Hsiao; Yi-Hsun Huang
Journal:  BMC Ophthalmol       Date:  2014-10-11       Impact factor: 2.209

Review 10.  Treatment algorithm of complications after filler injection: based on wound healing process.

Authors:  Joo Hyun Kim; Duk Kyun Ahn; Hii Sun Jeong; In Suck Suh
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

View more
  10 in total

1.  This month's guideline: Visual Loss Secondary to Cosmetic Filler Injection.

Authors:  Lee Walker; Martyn King
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

2.  Central retinal artery occlusion and optic neuropathy secondary to platelet rich plasma injection: a case report.

Authors:  Norashikin Maslan; Wan Haslina Wan Abdul Halim; Norshamsiah Md Din; Seng Fai Tang
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

3.  An Efficacy and Safety Study of Intra-arterial Recanalization of Occluded Ophthalmic Arteries in Patients with Monocular Blindness Caused by Injection of Hyaluronic Acid in Facial Tissues.

Authors:  Jianfeng Wang; Haiyang Shen; Tao Liu; Qian Li; Zhaoyang Lyu; Youtao Yu
Journal:  Aesthetic Plast Surg       Date:  2021-03-26       Impact factor: 2.326

4.  Sudden vision loss and neurological deficits after facial hyaluronic acid filler injection.

Authors:  Alexandra Lucaciu; Patrick Felix Samp; Elke Hattingen; Roxane-Isabelle Kestner; Petra Davidova; Thomas Kohnen; Jasmin Rudolph; Andreas Dietz; Helmuth Steinmetz; Adam Strzelczyk
Journal:  Neurol Res Pract       Date:  2022-07-18

Review 5.  Ocular Complications Following Autologous Fat Injections into Facial Area: Case Report of a Recovery from Visual Loss After Ophthalmic Artery Occlusion and a Review of the Literature.

Authors:  Aleksandra Szantyr; Michał Orski; Ida Marchewka; Mariusz Szuta; Małgorzata Orska; Jan Zapała
Journal:  Aesthetic Plast Surg       Date:  2017-02-23       Impact factor: 2.326

Review 6.  Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations.

Authors:  Fernando Urdiales-Gálvez; Nuria Escoda Delgado; Vitor Figueiredo; José V Lajo-Plaza; Mar Mira; Antonio Moreno; Francisco Ortíz-Martí; Rosa Del Rio-Reyes; Nazaret Romero-Álvarez; Sofía Ruiz Del Cueto; María A Segurado; Cristina Villanueva Rebenaque
Journal:  Aesthetic Plast Surg       Date:  2018-01-05       Impact factor: 2.326

7.  Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach.

Authors:  Philippe Snozzi; Jani A J van Loghem
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-12-17

8.  Treatment of Nasal Aging and Possible Long-term Nasal Enhancement with Fat Using Injectable Tissue Replacement.

Authors:  Steven R Cohen; Hayley A Womack; Adam T Hauch; Flore Delaunay; Angelo Trivisonno
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-17

Review 9.  The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): A consensus on practical guidance.

Authors:  M Dalvi Humzah; Saj Ataullah; ChenAn Chiang; Raman Malhotra; Robert Goldberg
Journal:  J Cosmet Dermatol       Date:  2018-06-08       Impact factor: 2.696

10.  Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.

Authors:  Jani van Loghem; David Funt; Tatjana Pavicic; Kate Goldie; Yana Yutskovskaya; Sabrina Fabi; Pieter Siebenga; Job Thuis; Joseph Hkeik; Jonathan Kadouch; Welf Prager; Nabila Azib; Gabriela Casabona; Steve Dayan; Shino Bay Aguilera; Philippe Snozzi; Peerooz Saeed
Journal:  J Cosmet Dermatol       Date:  2020-03-17       Impact factor: 2.696

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.